Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
18-22 May, 2025
Not Confirmed
Not Confirmed
19-22 May, 2025
Not Confirmed
Not Confirmed
20-22 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
18-22 May, 2025
Industry Trade Show
Not Confirmed
19-22 May, 2025
Industry Trade Show
Not Confirmed
20-22 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions
08 May 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/japans-shionogi-buy-torii-pharmaceutical-1-billion-nikkei-says-2025-05-07/
15 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/15/2882311/0/en/Verrica-Pharmaceuticals-Announces-Amendment-to-Company-s-Collaboration-and-License-Agreement-with-Torii-Pharmaceutical-Co-Ltd-to-Fund-Global-Pivotal-Phase-3-Clinical-Trial-to-Study.html
15 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/15/2796913/0/en/Verrica-Pharmaceuticals-Development-and-Commercialization-Partner-Torii-Pharmaceutical-Co-Ltd-Announces-Positive-Top-line-Results-from-a-Confirmatory-Phase-3-Trial-of-TO-208-for-th.html
01 Aug 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/08/01/2489298/0/en/Verrica-Pharmaceuticals-Announces-Start-of-Phase-3-Trial-of-VP-102-for-the-Treatment-of-Molluscum-Contagiosum-by-Torii-Pharmaceutical-Co-Ltd-in-Japan.html
17 Mar 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/fr/news-release/2021/03/17/2194392/0/en/Verrica-Pharmaceuticals-Announces-Exclusive-Licensing-Agreement-With-Torii-Pharmaceutical-Co-Ltd-To-Develop-and-Commercialize-VP-102-For-Molluscum-and-Common-Warts-in-Japan.html
05 Aug 2020
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2020/08/05/2073167/0/en/Verrica-Pharmaceuticals-Announces-Option-Agreement-with-Torii-Pharmaceutical-to-Develop-Commercialize-VP-102-in-Japan.html#:~:text=August%2005%2C%202020%2007%3A00,%7C%20Source%3A%20Verrica%20Pharmaceuticals%20Inc.&text=(Torii)%20granting%20Torii%20an%20exclusive,Japan%2C%20including%20VP%2D102.
ABOUT THIS PAGE